Concepedia

Joshua D. Thomas

JD

14

Publications

443

Citations

13

H-Index

2006

Active since

Affiliations

Mersana Therapeutics (United States)(Current)

University of Florida

Joshua D. Thomas is an author at Mersana Therapeutics (United States) specializing in pharmacology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2006–2025

14

Publications

14

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 99 citations

, , +20

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 70 citations · Full text

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates

Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid et al. · Journal of Medicinal Chemistry · 2023 · 44 citations · Full text

Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8<sup>+</sup>T Cells and TNF Receptor Superfamily Member 1a on Non-CD8<sup>+</sup>T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection

Srikanth Manam, Joshua D. Thomas, Weidang Li et al. · The Journal of Infectious Diseases · 2014 · 36 citations · Full text

Abstract 6706: Systemic administration of STING agonist antibody-drug conjugates elicit potent anti-tumor immune responses with minimal induction of circulating cytokines

Raghida A. Bukhalid, Jeremy R. Duvall, Naniye Mallı Cetinbas et al. · Cancer Research · 2020 · 25 citations

, , +20

Rows per page

1–5 of 14